236 related articles for article (PubMed ID: 7713476)
1. [Abdominal obesity and coronary heart disease. Pathophysiology and clinical significance].
Hauner H
Herz; 1995 Feb; 20(1):47-55. PubMed ID: 7713476
[TBL] [Abstract][Full Text] [Related]
2. [Non-pharmacological therapy of metabolic syndrome].
Wirth A
Herz; 1995 Feb; 20(1):56-69. PubMed ID: 7713478
[TBL] [Abstract][Full Text] [Related]
3. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
Van Gaal L
Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone and the metabolic syndrome.
Johannsson G; Bengtsson BA
J Endocrinol Invest; 1999; 22(5 Suppl):41-6. PubMed ID: 10442570
[TBL] [Abstract][Full Text] [Related]
5. [Effect of fat distribution on risk].
Toplak H
Acta Med Austriaca; 1998; 25(4-5):131-2. PubMed ID: 9879386
[TBL] [Abstract][Full Text] [Related]
6. [Obesity in type 2 diabetes, its features and specificity].
Xiang KS; Jia WP; Lu JX; Tang JL; Li J
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1768-72. PubMed ID: 15631769
[TBL] [Abstract][Full Text] [Related]
7. The obesity epidemic: pathophysiology and consequences of obesity.
Pi-Sunyer FX
Obes Res; 2002 Dec; 10 Suppl 2():97S-104S. PubMed ID: 12490658
[TBL] [Abstract][Full Text] [Related]
8. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
10. Abdominal fat distribution and insulin levels only partially explain adverse cardiovascular risk profile in Asian Indians.
Hodge AM; Dowse GK; Collins VR; Alberti KG; Gareeboo H; Tuomilehto J; Zimmet PZ
J Cardiovasc Risk; 1996 Jun; 3(3):263-70. PubMed ID: 8863097
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of multiple coronary risk factors in Punjabi Bhatia community: Jaipur Heart Watch-3.
Gupta R; Sarna M; Thanvi J; Rastogi P; Kaul V; Gupta VP
Indian Heart J; 2004; 56(6):646-52. PubMed ID: 15751521
[TBL] [Abstract][Full Text] [Related]
12. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature.
Türkoglu C; Duman BS; Günay D; Cagatay P; Ozcan R; Büyükdevrim AS
Obes Surg; 2003 Oct; 13(5):699-705. PubMed ID: 14627463
[TBL] [Abstract][Full Text] [Related]
13. [Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].
Völler H; Schmailzl KJ; Bjarnason-Wehrens B
Z Kardiol; 2004 Jul; 93(7):503-13. PubMed ID: 15243761
[TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular risk factors and prevention in women: similarities and differences].
Sclavo M
Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
[TBL] [Abstract][Full Text] [Related]
15. [Obese children and adolescents. Waist-hip ratio and cardiovascular risk].
Kalker U; Hövels O; Kolbe-Saborowski H
Monatsschr Kinderheilkd; 1993 Jan; 141(1):36-41. PubMed ID: 8446116
[TBL] [Abstract][Full Text] [Related]
16. Abdominal fat distribution and the metabolic syndrome.
Björntorp P
J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S26-8. PubMed ID: 1283766
[TBL] [Abstract][Full Text] [Related]
17. [Interrelation of visceral fat and muscle mass in non insulin-dependent diabetes (type II): practical implications].
Brun JF; Bringer J; Raynaud E; Renard E; Orsetti A
Diabetes Metab; 1997 Nov; 23 Suppl 4():16-34. PubMed ID: 9463021
[TBL] [Abstract][Full Text] [Related]
18. PASSCLAIM--body weight regulation, insulin sensitivity and diabetes risk.
Riccardi G; Aggett P; Brighenti F; Delzenne N; Frayn K; Nieuwenhuizen A; Pannemans D; Theis S; Tuijtelaars S; Vessby B
Eur J Nutr; 2004 Jun; 43 Suppl 2():II7-II46. PubMed ID: 15221353
[TBL] [Abstract][Full Text] [Related]
19. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.
Smith SR; Lovejoy JC; Greenway F; Ryan D; deJonge L; de la Bretonne J; Volafova J; Bray GA
Metabolism; 2001 Apr; 50(4):425-35. PubMed ID: 11288037
[TBL] [Abstract][Full Text] [Related]
20. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
Misra KB; Endemann SW; Ayer M
Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]